UBS rates FXJ as a buy with a target of $0.75 - reasons given are cost savings target and the proposed pay wallhttp://www.eurekareport.com.au/broker-alerts/all%20companies
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game